Denali Therapeutics Inc.DNLINASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+13.9%
5Y CAGR+17.3%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+13.9%/yr
vs +29.3%/yr prior
5Y CAGR
+17.3%/yr
Recent deceleration
Acceleration
-15.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.2x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $133.70M | +26.8% |
| 2024 | $105.44M | +2.0% |
| 2023 | $103.35M | +14.2% |
| 2022 | $90.47M | +14.4% |
| 2021 | $79.06M | +31.1% |
| 2020 | $60.33M | +29.8% |
| 2019 | $46.48M | +43.7% |
| 2018 | $32.35M | +106.3% |
| 2017 | $15.68M | +33.7% |
| 2016 | $11.73M | - |